NGL FINECHEM
|
The Current P/S Ratio of NGL FINECHEM is 1.88.
Share Price | ₹1,129.5 | May 07,2025 |
Market Cap | ₹700.3 Cr | |
Sales-TTM | ₹373.1 Cr | TTM-Consolidated Results |
Price/Sales | 1.88x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of NGL FINECHEM
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹700.3 Cr] as on May 07,2025
(/) Sales [ ₹373.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.88x ]
Thus, for NGL FINECHEM , the investors are currently willing to pay '1.88 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of NGL FINECHEM !
The chart below summarizes the trend in P/S Ratio of NGL FINECHEM over the last five years.
Historical PS (Price/Sales) ratio chart of NGL FINECHEM
PS Ratio Performance Analysis for NGL FINECHEM
- NGL FINECHEM 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.00x.
- NGL FINECHEM 's operated at median p/e ratio of 3.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NGL FINECHEM 's p/e ratio peaked in Mar2024 at 3.81x.
- NGL FINECHEM 's p/e ratio hit its five-year low in Mar2020 of 1.03x.
How does NGL FINECHEM 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
NGL FINECHEM | 373.1 | 1.88 | 700.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 8.28 | 427,406.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 17.97 | 163,113.0 |
CIPLA LTD | 26,981.2 | 4.52 | 121,869.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.85 | 111,345.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.10 | 96,801.0 |
MANKIND PHARMA LTD | 11,641.0 | 8.61 | 100,259.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.01 | 89,232.8 |
LUPIN LTD | 22,001.6 | 4.30 | 94,563.0 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.25 | 69,524.9 |
ABBOTT INDIA LTD | 6,243.2 | 10.30 | 64,299.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NGL FINECHEM 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.88x |
Max industry PS | 17.97x |
Median industry PS | 4.52x |
Average industry PS | 6.82x |
You may also like the below Video Courses